ISRCTN51530527
Suspended
未知
Virtual HDU Phase 4: Ambulatory monitoring system user interface integration and development.
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of Oxford
- Enrollment
- 78
- Status
- Suspended
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Stage A: Staff Focus Group/Interviews
- •1\. Any clinical staff member who uses SEND or measures patient vital signs
- •Study B: Locational testing of AMS
- •1\. Willing and able to give informed consent for participation in the study.
- •2\. Aged 18 years or above.
- •3\. Admitted to a surgical emergency unit (including post\-ICU patients) and not currently monitored with continuous monitoring
- •Study C: Usability Testing
- •1\. Any clinical staff member who uses SEND and measures patient vital signs
- •2\. Any staff member who may be an end user of a AMS\-SEND system
Exclusion Criteria
- •Stage A: Staff Focus Group/Interviews
- •1\. Any staff member who cannot give informed consent
- •Stage B: Locational testing of AMS
- •1\. Allergies to nickel.
- •2\. Intra\-cardiac device
- •3\. Already on continuous monitoring
- •4\. Diagnosed dementia
- •Stage C: Usability testing
- •1\. Any staff member who cannot give informed consent
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Home monitoring for acutely unwell patients being managed at home as part of a virual ward care pathway: a feasibility studyAcutely unwell patients receiving care from the Oxford University Hospital (OUH) acute hospital-at-home servicesSigns and SymptomsISRCTN11298549niversity of Oxford35
Active, not recruiting
Not Applicable
A Phase IV, Multi-Center, Active-Controlled, Observer-Blind Study to Evaluate the Safety of a Trivalent Subunit Influenza Vaccine Produced either in Mammalian Cell Culture (Optaflu®) or in Embryonated Hen Eggs (Agrippal®) in Adults and Elderly With and Without Underlying Medical Conditions, and to Evaluate the Immunogenicity in a Subset of Subjects With Underlying Medical Conditions.no medical condition: healthy subjectsEUCTR2007-002872-32-DEovartis Vaccines and Diagnostics S.r.l.
Completed
Not Applicable
A Multicenteric study to estimate the burden of rotavirus gastroenteritis among hospitalization due to diarrhea.Health Condition 1: null- Hospital-based surveillance of rotavirus gastroenteritis in children â?¤ 59 months of ageCTRI/2012/03/002475Shantha Biotechnics Limited2,000
Active, not recruiting
Phase 1
A Phase IV, Single-Centre, Observer-Blind, Controlled, Randomized Study to Compare the Safety and Immunogenicity of Fluvirin® to Influvac® Administered to Healthy Children 3 to 12 Years of Age. - Fluvirin Paediatric TrialEUCTR2006-002649-35-GBovartis Vaccines and Diagnostics S.r.l.
Not yet recruiting
Phase 4
Hospital centralized monitoring of clinical safety of Shenkang Injection after marketing/AITMCTR2100005034The First Affiliated Hospital of He'nan University of Chinese Medicine